Mesa Laboratories (MLAB) news
Recent news
Micro Systemation: MSAB (Micro Systemation AB, publ) provides preliminary update for the third quarter of 2026 – Operating profit (EBIT) exceeds expectations
AInvest Wire · 1d agoMoody's Ratings affirms WePA's BA3 CFR, changes outlook to stable from positive
AInvest Wire · 2d agoMesa Laboratories, Inc. - Expect savings plan to be fully reflected in our annualized cost structure by end of fiscal year 2028
Mesa Laboratories, Inc. has indicated that its cost-saving initiatives are progressing as planned, with the company expecting these measures to be fully integrated into its annualized cost structure by the end of fiscal year 2028. The company’s focus on operational efficiency is part of a broader…
AInvest Wire · 2d agoMesa Laboratories. - Cost reductions concentrated primarily in clinical genomics division, with additional reductions in corporate functions
Mesa Laboratories has announced cost reduction initiatives across its operations, with the majority of cuts focused on its clinical genomics division. These measures are part of a broader strategy to streamline operations and improve financial efficiency. In addition to reductions in the clinical…
AInvest Wire · 2d agoMesa Laboratories, Inc. - As part of restructuring program, we will eliminate approximately 40 positions, or approximately 6% of total employee base
AInvest Wire · 2d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.